LTIMindtree Limited (LTIM) AI Stock Analysis

• Market Cap: ₹1.50T
• Dividend Yield: 2.17%
• Average Volume (3M): 11.48K
• Price to Earnings (P/E): 31.7
• Beta (1Y): 1.22
• Revenue Growth: 7.64%
• EPS Growth: 3.35%
• Country: IN
• Employees: 84,307
• Sector: Technology
• Sector Strength: 88
• Industry: Information Technology Services
• EPS (TTM): 42.30
• Shares Outstanding: 296,416,780
• 10 Day Avg. Volume: 16,974
• 30 Day Avg. Volume: 11,477
• PEG Ratio: 100.32
• Price to Book (P/B): 5.78
• Price to Sales (P/S): 3.45
• P/FCF Ratio: 36.45
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ₹5,241.58
• Price Target Upside: 3.60% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 12

• Rating: 69 Neutral
• Price Target: ₹5,696.00 ▲(12.58% Upside)

LTIMindtree Limited's overall stock score is driven by its strong financial performance, characterized by robust profit margins and a solid balance sheet. However, the technical analysis presents mixed signals, and the valuation suggests the stock may be overvalued. The absence of earnings call and corporate events data limits further insights.

LTIMindtree Limited Business Overview & Revenue Model

Company Description

LTIMindtree Limited, a technology consulting and digital solutions company, provides information technology services and solutions in India, North America, Europe, the Asia Pacific, and internationally. The company operates through Banking, Financial Services & Insurance; Manufacturing; Energy & Utilities; High-Tech, Media & Entertainment; and CPG, Retail, Pharma & Others segments. It offers application development, maintenance and outsourcing, enterprise, infrastructure management, testing, digital, and platform-based solutions. LTIMindtree Limited has a strategic collaboration agreement with Amazon Web Services, Inc.; and a strategic partnership with eClinicalHealth Limited to enhance digital innovation in clinical trials management process for patient centric drug development. The company was formerly known as Larsen & Toubro Infotech Limited and changed its name to LTIMindtree Limited in November 2022. The company was incorporated in 1996 and is based in Mumbai, India. LTIMindtree Limited operates as a subsidiary of Larsen & Toubro Limited.

How the Company Makes Money

LTIMindtree makes money primarily through providing IT services and solutions to its clients, which include large enterprises across diverse industries. The company's revenue model is based on service contracts, project-based fees, and managed services agreements. Key revenue streams include digital transformation projects, cloud migration and management, application development and maintenance, and IT consulting services. LTIMindtree's earnings are bolstered by long-term client partnerships, strategic alliances with technology leaders, and investments in innovation and talent development. The company also benefits from a global delivery model, which allows it to efficiently serve clients in different regions while optimizing operational costs.

LTIMindtree Limited Financial Statement Overview

Summary

LTIMindtree Limited showcases a robust financial profile characterized by strong revenue growth, profitability, and cash flow generation. The balance sheet is well-capitalized, providing financial flexibility. While the company has demonstrated effective leverage management and operational efficiency, minor pressures on margins and an increase in debt warrant ongoing attention.

Income Statement

LTIMindtree Limited has demonstrated strong revenue growth, increasing from 108,786 million to 380,081 million over five years. The gross profit margin has remained robust, with a 28.3% margin in the latest period. The net profit margin is also healthy at 12.1%, indicating efficient cost management. However, a slight dip in EBIT margin from 15.7% to 14.5% suggests some margin pressures. Overall, the company's income statement reflects strong growth and profitability.

Balance Sheet

The balance sheet shows a solid equity base, with stockholders’ equity rising from 54,040 million to 226,983 million. The debt-to-equity ratio is low, indicating conservative leverage levels, at 0.10 in the latest period. The equity ratio is strong at 74.1%, showcasing financial stability. The improvements in cash and investments further enhance the liquidity position. Despite the positive outlook, the slight increase in total debt warrants monitoring.

Cash Flow

LTIMindtree Limited exhibits strong cash flow dynamics, with operating cash flow consistently supporting net income, reflected in a high operating cash flow to net income ratio. Free cash flow has grown significantly, increasing from 13,970 million to 35,962 million, demonstrating effective cash management and operational efficiency. The company’s ability to generate substantial free cash flow relative to net income highlights its financial resilience.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	387.06B	380.08B	355.17B	331.83B	261.09B	123.70B
Gross Profit	104.22B	107.54B	94.06B	123.03B	62.64B	47.76B
EBITDA	74.42B	74.85B	70.89B	66.65B	60.14B	29.92B
Net Income	47.19B	45.99B	45.82B	44.08B	39.48B	19.36B
Balance Sheet
Total Assets	307.46B	306.30B	275.63B	234.96B	205.82B	107.09B
Cash, Cash Equivalents and Short-Term Investments	101.68B	112.36B	95.72B	76.64B	72.24B	43.90B
Total Debt	22.27B	21.87B	20.71B	15.41B	13.91B	7.98B
Total Liabilities	80.50B	79.19B	75.37B	68.97B	62.90B	34.02B
Stockholders Equity	226.83B	226.98B	200.17B	165.92B	142.87B	73.03B
Cash Flow
Free Cash Flow	38.35B	35.96B	48.26B	21.55B	21.93B	21.28B
Operating Cash Flow	43.31B	45.46B	56.70B	30.95B	32.51B	24.00B
Investing Cash Flow	-13.23B	-17.38B	-39.12B	-3.31B	-16.45B	-16.56B
Financing Cash Flow	-27.23B	-25.74B	-22.69B	-19.32B	-16.80B	-5.09B

LTIMindtree Limited Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 5059.50
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:LTIM, the sentiment is Negative. The current price of 5059.5 is below the 20-day moving average (MA) of 5270.04, below the 50-day MA of 5185.35, and below the 200-day MA of 5203.37, indicating a bearish trend. The MACD of 9.59 indicates Positive momentum. The RSI at 38.25 is Neutral, neither overbought nor oversold. The STOCH value of 4.93 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:LTIM.

LTIMindtree Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
WIPRO	77 Outperform	₹2.47T	18.31	15.49%	4.67%	0.41%	20.30%
PERSISTENT	72 Outperform	₹774.58B	50.50	―	0.71%	22.44%	26.98%
LTIM	69 Neutral	₹1.50T	31.74	―	2.17%	7.64%	3.35%
COFORGE	68 Neutral	₹515.02B	51.63	12.73%	1.00%	44.02%	18.92%
MPHASIS	66 Neutral	₹502.81B	28.82	17.68%	2.16%	8.11%	10.73%
TECHM	55 Neutral	₹1.38T	27.42	15.54%	3.20%	2.88%	79.99%
Sector *	61 Neutral	$37.18B	12.37	-10.20%	1.83%	8.50%	-7.62%